Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Burrill Life Sciences Media Group was the media and publishing division of Burrill & Company, a once-prominent venture capital firm focused on the life sciences industry. The group served as a primary source of market intelligence and strategic analysis, publishing the influential monthly "The Burrill Report" and a series of annual industry state-of-the-union books. It also hosted prestigious industry events, including the Burrill Personalized Medicine Meeting and various regional biotech conferences. Through its publications and forums, the group provided a platform for industry leaders to discuss trends in biotechnology, healthcare policy, and financial markets. Operations for the media group effectively ceased in the mid-2010s following the legal downfall of its parent company and founder, G. Steven Burrill. The group's legacy remains tied to its role in documenting the growth of the modern biotechnology era during the late 1990s and early 2000s.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Burrill Life Sciences Media Group.